L. García-León

Peripheral blood mobilization of different lymphocyte and dendritic cell subsets with the use of intermediate doses of G-CSF in patients with non-Hodgkin’s lymphoma and multiple myeloma

H. Mayani, J. Vela-Ojeda, M. Moreno-Lafont, 2006, Annals of Hematology.

CD4+ CD25+ lymphocyte and dendritic cell mobilization with intermediate doses of recombinant human granulocyte colony-stimulating factor in healthy donors.

H. Mayani, J. Vela-Ojeda, M. Moreno-Lafont, 2005, Stem cells and development.

Prospective randomized clinical trial comparing high-dose ifosfamide + GM-CSF vs high-dose cyclophosphamide + GM-CSF for blood progenitor cell mobilization

J. Vela-Ojeda, A. Rosas-Cabral, F. Tripp-Villanueva, 2000, Bone Marrow Transplantation.

Clinical relevance of NK, NKT, and dendritic cell dose in patients receiving G-CSF-mobilized peripheral blood allogeneic stem cell transplantation

H. Mayani, J. Vela-Ojeda, M. Moreno-Lafont, 2006, Annals of Hematology.

Intermediate doses of melphalan and dexamethasone are better than vincristine, adriamycin, and dexamethasone (VAD) and polychemotherapy for the treatment of primary plasma cell leukemia

J. Vela-Ojeda, A. Rosas-Cabral, M. G. Garcia-Ruiz Esparza, 2002, Annals of Hematology.

Donor lymphocyte infusions for relapse of chronic myeloid leukemia after allogeneic stem cell transplantation: prognostic significance of the dose of CD3+ and CD4+ lymphocytes

J. A. Aviña-Zubieta, G. Galindo-Rodríguez, J. Vela-Ojeda, 2004, Annals of Hematology.

Allogeneic bone marrow transplantation for chronic myeloid leukemia: a single center experience.

J. Vela-Ojeda, A. Rosas-Cabral, F. Tripp-Villanueva, 2000, Archives of medical research.